gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
A method for treating cancer using a specific compound.
|
gptkbp:applicationNumber
|
10/703,174
|
gptkbp:applicationPublication
|
gptkb:US_2004/0123456_A1
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B1
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
NCT00012345
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 29, 2021
|
gptkbp:fieldOfInvention
|
cancer treatment
|
gptkbp:fieldOfUse
|
pharmaceuticals
|
gptkbp:filingDate
|
March 29, 2004
|
gptkbp:grantDate
|
September 14, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,022 C8
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:Bob_Brown
gptkb:John_Doe
|
gptkbp:issuedOn
|
September 14, 2004
|
gptkbp:language
|
English
|
gptkbp:legalStatus
|
granted
|
gptkbp:material
|
compound X
|
gptkbp:patentAbstract
|
A method for treating cancer using compound X.
|
gptkbp:patentAssignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:patentCitation
|
gptkb:US_5,123,456_A
gptkb:US_7,123,456_B1
|
gptkbp:patentClaim
|
method of treatment
|
gptkbp:patentClassification
|
C07D 401/12
|
gptkbp:patentExpiration
|
March 29, 2021
|
gptkbp:patentFamily
|
US_6,789,022_C8_family
|
gptkbp:patentField
|
pharmaceutical composition
|
gptkbp:patentFilingDate
|
March 29, 2001
September 14, 2004
March 29, 2004
|
gptkbp:patentInventor
|
gptkb:John_Doe
|
gptkbp:patentNumber
|
6,789,022
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentStatus
|
active
|
gptkbp:patentType
|
gptkb:US_6,800,300_B2
utility
granted patent
|
gptkbp:priorityDate
|
March 29, 2001
|
gptkbp:relatedPatent
|
gptkb:US_6,800,300_B2
|
gptkbp:relatedTo
|
gptkb:US_6,800,300_B2
|
gptkbp:research_areas
|
oncology
|
gptkbp:status
|
active
|
gptkbp:title
|
Method for treating cancer
|